Related Experiment Video
Updated: Jul 18, 2025

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
Published on: July 6, 2016
Fungal pathogens and COVID-19
Ashutosh Singh1, Amtoj Kaur2, Anuradha Chowdhary1
1Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India; National Reference Laboratory for Antimicrobial Resistance in Fungal Pathogens, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Abstract:
COVID-19 pandemic highlighted the complications of secondary fungal infections that occurred globally in severe cases of coronavirus disease managed in the intensive care units. Furthermore, varied underlying host factors, such as preexisting immunosuppression, the use of immunomodulatory agents, and invasive procedures predisposing lung tissues to fungal colonization and proliferation, caused increased susceptibility to fungal infections in COVID-19 patient populations. These invasive fungal infections directly impact the overall length of hospitalization and mortality. The most commonly reported fungal infections in patients with COVID-19 include aspergillosis, invasive candidiasis, and mucormycosis. An overall worldwide increase in the prevalence of candidiasis and aspergillosis was observed in COVID-19 patients , whereas outbreaks of mucormycosis were mainly recorded from India. Diagnostic challenges and limited antifungal treatment options make secondary fungal infections among COVID-19 patients more burdensome, which results in improper management and increased mortality.
Insights
The COVID-19 pandemic saw a rise in secondary fungal infections like aspergillosis and candidiasis, increasing mortality. Diagnostic and treatment challenges worsen outcomes for these invasive fungal infections in critically ill patients.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Mycology
Background:
- The COVID-19 pandemic has been associated with a significant increase in secondary fungal infections among severe cases.
- Factors such as immunosuppression, immunomodulatory therapies, and invasive procedures contribute to heightened susceptibility in COVID-19 patients.
- These fungal infections exacerbate patient outcomes, leading to prolonged hospitalization and increased mortality.
Purpose of the Study:
- To review the epidemiology and clinical impact of secondary fungal infections in COVID-19 patients.
- To highlight common fungal pathogens and their global distribution in this patient population.
- To discuss the challenges in diagnosis and treatment of these infections.
Main Methods:
- Literature review of studies reporting fungal infections in COVID-19 patients.
- Analysis of reported fungal species, prevalence, and geographical distribution.
- Examination of diagnostic hurdles and therapeutic limitations.
Main Results:
- Aspergillosis, invasive candidiasis, and mucormycosis are the most frequently reported fungal infections.
- A global increase in candidiasis and aspergillosis was noted, with mucormycosis outbreaks primarily in India.
- These infections significantly impact patient morbidity and mortality.
Conclusions:
- Secondary fungal infections pose a substantial threat to COVID-19 patients, particularly those in intensive care.
- Diagnostic difficulties and limited treatment options contribute to poor management and higher mortality rates.
- Further research and improved clinical strategies are needed to address this growing public health concern.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Fungal Phylum Basidiomycota
Overview of Fungi
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

